✦ LIBER ✦

Improved survival with nonselective beta blockers

✍ Scribed by Ulrich Thalheimer; Jaime Bosch; David Patch; Andrew Burroughs

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 48 KB
Volume: 48
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22600

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carvedilol—A new nonselective beta block

Carvedilol—A new nonselective beta blocker

✍ Ewan Forrest; Adrian Stanley; Peter Hayes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Is hydrophobia necessary for the hepatol

Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?

✍ Marco Senzolo; Elena Nadal; Evangelos Cholongitas; Andrew K. Burroughs 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

We read with interest the article by Vibert et al. 1 recently published in HEPATOLOGY. The authors described their single-center experience with liver transplantation for hepatocellular carcinoma (HCC) in human immunodeficiency virus (HIV)-positive patients (21 cases) and compared those patients to

Do partial agonist beta-blockers have im

Do partial agonist beta-blockers have improved clinical utility?

✍ J. D. Fitzgerald 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 956 KB

Effects of beta-blockers on survival for

Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites

✍ Gin-Ho Lo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

Deleterious effects of beta-blockers on

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

✍ Mevlut Kurt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Deleterious effects of beta-blockers on

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

✍ Thomas Sersté; Christian Melot; Claire Francoz; François Durand; Pierre-Emmanuel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

Beta-blockers may have a negative impact on survival in patients with cirrhosis and refractory ascites. The aim of this study was to evaluate the effect of the administration of beta-blockers on long-term survival in patients with cirrhosis and refractory ascites. We performed a single-center, obser